Alexander J. Towbin · MRI of paediatric liver tumours: How we review and report
Follow
Article1 min read·Published Aug 2016Older

MRI of paediatric liver tumours: How we review and report

pubmed.ncbi.nlm.nih.gov shows its articles on its own site.

Read the article on pubmed.ncbi.nlm.nih.gov ↗

Article · Aug 2016 · 1 min read

In brief

In brief

This review provides radiologists with a practical framework for MRI evaluation of pediatric liver masses, emphasizing sequence selection and contrast agent use to differentiate benign lesions from malignancies. The article details imaging features of hepatoblastoma and hepatocellular carcinoma while addressing common diagnostic mimickers like FNH and adenomas.

Written by the GCMD Library team from the article.

Alexander J. Towbin

Liver tumours are fortunately rare in children. Benign tumours such as haemangiomas and cystic mesenchymal hamartomas are typically seen in infancy, often before 6 months of age. After that age, malignant hepatic tumours increase in frequency. The differentiation of a malignant from benign lesion on imaging can often negate the need for biopsy. Ultrasound is currently the main screening tool for suspected liver pathology, and is ideally suited for evaluation of hepatic lesions in children due to their generally small size. With increasing research, public awareness and parental anxiety regarding radiation dosage from CT imaging, MRI is now unquestionably the modality of choice for further characterisation of hepatic mass lesions.Nevertheless the cost, length of imaging time and perceived complexity of a paediatric liver MR study can be intimidating to the general radiologist and referring clinician. This article outlines standard MR sequences utilised, reasons for their utilisation, types of mixed hepatocyte specific/extracellular contrast agents employed and imaging features that aid the interpretation of paediatric liver lesions. The two commonest paediatric liver malignancies, namely hepatoblastoma and hepatocellular carcinoma are described. Differentiation of primary hepatic malignancies with metastatic disease and mimickers of malignancy such as focal nodular hyperplasia (FNH) and hepatic adenomas are also featured in this review..Imaging should aim to clarify the presen

Statements in this article

  1. Benign liver tumours such as haemangiomas and cystic mesenchymal hamartomas are typically seen in infancy, often before 6 months of age.

    Established
  2. After 6 months of age, malignant hepatic tumours increase in frequency.

    Established
  3. Differentiation of a malignant from benign lesion on imaging can often negate the need for biopsy.

    Established
  4. Ultrasound is currently the main screening tool for suspected liver pathology in children.

    Established
  5. MRI is now the modality of choice for further characterisation of hepatic mass lesions in children.

    Recommendation

Read it at the source ↗

Try
Intelligent Search· scoped to this article · not medical adviceSearch the whole library →
GCMD Library — educational content from recorded physician discussions, not medical advice.